Par Pharmaceutical: High-Quality, Cost-Effective Generic Products Par Pharmaceutical, headquartered in Chestnut Ridge, New York, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a robust research and development (R&D) pipeline of potential products. Par is an operating company of Endo International plc, a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.
Looking for a particular Par Pharmaceutical employee's phone or email?
The Par Pharmaceutical annual revenue was $238.6 million in 2026.
Ted Leggett is the VP Quality Generics of Par Pharmaceutical.
824 people are employed at Par Pharmaceutical.
Par Pharmaceutical is based in Chestnut Ridge, New York.
The NAICS codes for Par Pharmaceutical are [32, 551, 325, 55].
The SIC codes for Par Pharmaceutical are [671, 67, 28, 283].